Results 91 to 100 of about 2,124,017 (159)

Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review

Reviews in Cardiovascular Medicine
Medical devices for tricuspid regurgitation have emerged as viable treatment options for patients who do not respond to drug therapy or who are unsuitable for open-heart surgery due to high surgical risk. Recently, numerous new medical devices have been proposed and approved for use.
Eugenia Piragine, Vincenzo Calderone, Andrea Messori, Sabrina Trippoli, Sara Veneziano   +4 more
openaire   +3 more sources

Functional Tricuspid Regurgitation in the Transcatheter Aortic Valve Replacement Population and Emerging Transcatheter Tricuspid Valve Interventions [PDF]

Transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic valve disease. However, its success has brought attention to concurrent tricuspid valve disease and the inadequacy of treatments.
Molly Silkowski, Payton Kendsersky, Nicholas Amoroso   +2 more
core   +1 more source

Advancements in transcatheter tricuspid valve repair and replacement: a state-of-the-art review with echocardiographic outcomes

Global Cardiology
Tricuspid regurgitation (TR) affects over 1.6 million individuals in the United States, with a one-year mortality rate of 36.1% and a five-year survival below 30%.
Asad Gul Rao, Syed Sarmad Javaid, Ahmed Mustafa Rashid, Fawaz Alenezi   +3 more
doaj   +1 more source

Real‐World Experience in Tricuspid Transcatheter Edge‐to‐Edge Repair: Transcatheter Tricuspid Valve Repair in Spain Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Significant tricuspid regurgitation (TR) is associated with increased morbidity and mortality. The development of transcatheter valve repair therapies has opened a wide range of opportunities for treatment of patients with high surgical risk ...
Antonio Sisinni, Manuel Barreiro‐Perez, Xavier Freixa, Dabit Arzamendi, Vanessa Moñivas, Fernando Carrasco‐Chinchilla, Manuel Pan, Luis Nombela‐Franco, Isaac Pascual, Tomás Benito‐González, Ruth Perez, Iván Gómez‐Blázquez, Ignacio J. Amat‐Santos, Ignacio Cruz‐González, Ángel Sánchez‐Recalde, Ana Belén Cid Alvarez, Laura Sanchis, Berenice Caneiro‐Queija, Chi Hion Li, Maria del Trigo, Jose David Martínez‐Carmona, Dolores Mesa, Eduardo Pozo, Pablo Avanzas, Pedro Cepas‐Guillén, Rodrigo Estévez‐Loureiro   +25 more
doaj   +1 more source

Reversible Right-to-Left Shunt After Mitral TEER Resolved by Tricuspid TEER

JACC: Case Reports
Background: Iatrogenic atrial septal defects are common after transseptal interventions and are usually clinically insignificant; however, under specific hemodynamic conditions, they may result in clinically relevant right-to-left shunting and hypoxemia.
Özlem Önder, MD, Aysel Akhundova, MD, Ekrem Güler, MD   +2 more
doaj   +1 more source

Rapid Native and Bioprosthetic Tricuspid Valve Degeneration in Carcinoid Heart Disease

JACC: Case Reports
Background: Carcinoid heart disease (CaHD) is a severe complication of metastatic neuroendocrine tumors characterized by serotonin-mediated fibrotic degeneration of right-sided cardiac valves.
Lucia Trabucchi, MS, Richiele Forgiarini, MD, Maria I. Ardid, MD, Abraham Abdemur, MD, Raul E. Herrera, MD, Rodolfo Arce, MD, Tom C. Nguyen, MD, Ramon Quesada, MD, Elliott J. Elias, MD, Nish Patel, MD   +9 more
doaj   +1 more source

Persistent Severe Tricuspid Regurgitation After Mitral Transcatheter Edge-to-Edge Repair: Prognostic Implications of Guideline-Based Eligibility for Transcatheter Tricuspid Valve Intervention

Structural Heart
Background: Persistent tricuspid regurgitation (TR) after mitral transcatheter edge-to-edge repair (M-TEER) is common and associated with adverse outcomes.
Moritz Kühlein, MD, Jule Tervooren, Vera Fortmeier, MD, Amelie Hesse, Elena Rippen, MD, Michelle Fett, Héctor Alfonso Alvarez Covarrubias, MD, Moritz von Scheidt, MD, Ferdinand Roski, Muhammed Gerçek, MD, Shinsuke Yuasa, MD, PhD, N. Patrick Mayr, MD, Erion Xhepa, MD, PhD, Karl-Ludwig Laugwitz, MD, Michael Joner, MD, Volker Rudolph, MD, Teresa Trenkwalder, MD, Tobias Rheude, MD, Mark Lachmann, MD   +18 more
doaj   +1 more source

Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies

, 2018
Moving treanscatheter valve intervention towards atrioventricular (AV) valves implies increasing complexity. Part of the knowledge that has been generated during the development of mitral devices can be transferred to the tricuspid valve (TV).
Maisano, Francesco, Joachim Schofer, Martin B Leon, Hahn, Rebecca T, Shingo Kuwata, Gaetano Thiene, Paolo Denti, Alfieri, Ottavio, Ottavio Alfieri, Nickenig, Georg, Schofer, Joachim, Fabian Nietlispach, Basso, Cristina, Kuwata, Shingo, Pozzoli, Alberto, Reisman, Mark, Thiene, Gaetano, Mark Reisman, Rebecca T Hahn, Nietlispach, Fabian, Cristina Basso, Alberto Pozzoli, Denti, Paolo, Francesco Maisano, Leon, Martin B, Maurizio Taramasso, Georg Nickenig, Taramasso, Maurizio, Hahn RT, Thiene G, Denti P, Basso C, Nietlispach F, Schofer J, Nickenig G, Taramasso M, Alfieri O, Reisman M, Pozzoli A, Maisano F, Kuwata S, Leon MB   +41 more
core   +1 more source

Enhancing Access to Transcatheter Tricuspid Interventions Amid Disparities

JACC: Advances
[Figure: see text]
Sachin S. Goel, Safi U. Khan
openaire   +3 more sources

Transjugular tricuspid valve‐in‐ring replacement using the novel system under three‐dimensional printing guidance

ESC Heart Failure
Recurrent tricuspid regurgitation after failed ring annuloplasty is associated with high mortality rates and unfavourable clinical outcomes. Transcatheter tricuspid valve‐in‐ring (TVIR) replacement offers an alternative to high‐risk surgical reoperation,
Yiwei Wang, Yang Liu, Jian Yang
doaj   +1 more source